FCA to detail position limits regime in Q4
FCA says identifying 'economically equivalent' OTC products is the responsibility of firms
Existing Subscriber?
If you are an existing subscriber please sign in to read this article in full.
Sign InSign up for a free trial
Take a complimentary trial to the FOW Marketing Intelligence Platform and gain access to a wealth of news, analysis and data across the Asset Management, Securities Finance, Custody, Fund Services and Derivatives markets.
Sign up for a free trial